OKYO Pharma Limited (“OKYO” or the “Company”) – OKYO Pharma announces Successful Completion of a Pre-IND Meeting with the FDA on the Development of OK-101 to Treat Dry Eye Disease
OK-101 First-in-Human Trial planned as Phase 2 Trial incorporating Primary Efficacy Endpoints covering Signs and…
AISIX Solutions Inc. and Re: Drying Equipment Inc. Announce Update to Proposed Reverse Takeover Transaction
Arkansas Governor Sarah Huckabee Sanders Visits CoorsTek Benton Facility
ImagineAR Announces Agreement to Acquire s3iai Inc.
ANK Constructions & Interiors Launches No-Cost Snagging Inspections for Dubai Property Owners
NamSys Announces Normal Course Issuer Bid